China's Food and Drug Administration announced Tuesday that clinical data from four Taiwanese hospitals can be used when applying for drug permits in China, a "breakthrough" that industry leaders said will give Taiwan a leg up in developing into an Asia-Pacific hub for pharmaceutical research and trials.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares stage strong rebound, led by tech, financial stocks
06/09/2026 04:41 PM - Business
U.S. dollar closes higher on Taipei forex market
06/09/2026 04:15 PM - Society
Taipei to hold free migrant worker health check-ups June 14
06/09/2026 03:40 PM - Society
Japan mitten crab imports rejected after found contaminated with dioxins
06/09/2026 03:38 PM - Society
MOFA to further relax online passport renewal service from July
06/09/2026 03:31 PM